This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of levodopa decarbox-comt-inhibitor
PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1088 |
4. Check minimum number of events
Min. number of events
3
|
1088 |
5. Include endpointsNone |
1088 |
6. Filter based on genotype QC (FinnGen only) |
1088 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of levodopa decarbox-comt-inhibitor
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1088 | 403 | 685 |
| Unadjusted period prevalence (%) | 0.24 | 0.14 | 0.30 |
| Median age at first event (years) | 69.57 | 68.58 | 70.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 932
- Matched controls
- 9317
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
193
Kela drug reimbursment
Rasagiline
416.7
323.0
375
15
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
3866.5
323.0
917
140
N87
ICPC
Parkinsonism
153.5
323.0
449
56
N04BD01
ATC
selegiline; oral
318.9
323.0
581
48
G20
ICD-10 Finland
Parkinson disease
2865.5
323.0
914
156
N04BC04
ATC
ropinirole; oral
198.5
323.0
379
32
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
1509.3
323.0
903
193
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
323.0
932
10
N04BD02
ATC
rasagiline; oral
447.4
323.0
433
18
N04BC05
ATC
pramipexole; oral
39.7
323.0
588
384
N04BX02
ATC
entacapone; oral
295.7
229.2
225
10
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
134.4
199.9
209
20
N04BC09
ATC
rotigotine; transdermal
211.8
171.3
173
10
N06DA03
ATC
rivastigmine; oral, transdermal
14.7
138.3
246
221
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
764.6
137.4
132
*
N04BB01
ATC
amantadine; oral
43.0
134.0
167
47
N05AH04
ATC
quetiapine; oral
7.5
126.0
347
679
N03AE01
ATC
clonazepam; systemic
11.9
115.1
226
244
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
279.4
99.8
100
*
XA800
NOMESCO Finland
Neuropsychological investigation
12.7
65.6
121
108
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
27.1
65.6
91
37
R25.1
ICD-10 Finland
Tremor, unspecified
11.5
63.9
124
123
N04AA02
ATC
biperiden; systemic
20.2
62.5
95
52
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
132.6
58.6
62
5
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
298.7
55.8
56
*
G04BD12
ATC
mirabegron; oral
4.3
55.3
240
701
N04BC06
ATC
cabergoline; oral (dopamine agonists)
151.5
54.5
57
*
R1250
NOMESCO Finland
Evaluation of functional capability
14.0
53.2
93
73
H02AA02
ATC
fludrocortisone; oral
25.0
52.3
74
32
SPAT1229
SPAT
Assessment of need for aid
4.9
51.3
186
451
AA1AD
NOMESCO Finland
CT of head and brain
2.9
45.8
380
1784
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.4
44.9
146
311
N04BC02
ATC
pergolide; oral
161.0
44.2
46
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.8
43.9
411
2065
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.2
42.6
276
1086
A06AD11
ATC
lactulose; oral
3.2
42.5
269
1042
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
29.1
40.8
55
20
R53
ICD-10 Finland
Malaise and fatigue
2.9
38.7
289
1240
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
13.1
36.0
64
52
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
41.9
35.6
44
11
C07AA05
ATC
propranolol; systemic
3.1
35.2
222
842
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.8
34.7
123
285
N06AX11
ATC
mirtazapine; oral
2.5
33.8
359
1864
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
33.5
141
386
L28
ICPC
Limited function/disability (L)
2.8
33.2
260
1134
A28
ICPC
Limited function/disability NOS
2.7
32.7
267
1191
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.1
32.4
211
812
I95.1
ICD-10 Finland
Orthostatic hypotension
5.3
32.1
103
213
R4130
NOMESCO Finland
Speech therapy
8.4
31.1
70
89
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
30.7
361
1955
N19
ICPC
Speech disorder
12.1
30.0
55
48
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.6
28.3
68
96
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
27.8
200
816
G02CB01
ATC
bromocriptine; systemic
20.8
27.1
40
20
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
278.6
26.9
27
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.6
26.4
96
227
SPAT1216
SPAT
Assessment of functional ability
2.5
26.3
243
1143
N05BA04
ATC
oxazepam; oral
2.4
26.0
279
1417
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.7
25.5
91
211
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
25.2
115
336
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
24.9
243
1171
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.6
24.4
120
372
XF606
NOMESCO Finland
Ortostatic test
17.4
23.7
37
22
N06AB10
ATC
escitalopram; oral
2.7
23.5
188
810
N03AX12
ATC
gabapentin; oral
2.6
23.3
189
818
N04BC07
ATC
apomorphine; parenteral
+∞
23.0
22
*
N29
ICPC
Neurological sympt/complt other
7.5
22.6
54
76
R47.1
ICD-10 Finland
Dysarthria and anarthria
13.1
22.3
39
31
D21
ICPC
Swallowing problem
8.9
22.1
47
55
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.9
21.2
60
107
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
20.6
209
1014
SPAT1234
SPAT
Support of social functional capacity
3.5
20.2
100
311
R35
ICD-10 Finland
Polyuria
3.2
19.8
110
371
U04
ICPC
Incontinence urine
3.8
19.7
88
251
JDB10
NOMESCO Finland
Percutaneous gastrostomy
10.1
19.7
39
40
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
19.5
182
846
R13
ICD-10 Finland
Dysphagia
3.2
18.9
103
345
S01.0
ICD-10 Finland
Open wound of scalp
2.9
18.8
121
453
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
18.7
104
350
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
17.8
17
*
N04BX04
ATC
opicapone; oral
+∞
17.8
17
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
17.7
199
1008
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
17.1
108
399
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
22.3
16.9
24
11
R1260
NOMESCO Finland
Evaluation of communicative skills
6.6
16.7
43
68
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
16.7
16
*
G04BD09
ATC
trospium; oral
4.7
16.7
57
127
N30.0
ICD-10 Finland
Acute cystitis
2.4
16.5
152
699
S72.0
ICD-10 Finland
Fracture of neck of femur
3.6
16.0
75
224
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
15.9
119
488
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.4
15.4
78
247
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
29.1
15.2
20
7
M48.0
ICD-10 Finland
Spinal stenosis
2.2
15.0
173
880
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.3
14.6
54
131
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
8.0
14.4
32
41
RF120
NOMESCO Finland
NA
9.3
14.3
29
32
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
22.7
14.2
20
9
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.0
14.1
82
287
K59.09
ICD-10 Finland
Constipation, unspecified
2.8
14.1
93
351
W19
ICD-10 Finland
Unspecified fall
2.5
13.8
119
525
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
13.7
57
154
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.2
13.6
42
84
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.9
13.6
56
150
N04BC01
ATC
bromocriptine; oral
141.9
13.5
14
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
13.4
103
427
Z50.5
ICD-10 Finland
Speech therapy
7.5
13.0
30
41
G04BD11
ATC
fesoterodine; oral
3.7
12.9
56
157
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.2
12.7
48
119
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
12.7
53
144
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
70.8
12.6
14
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
12.3
120
562
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
12.3
105
462
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.9
12.2
75
272
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
7.9
12.2
27
35
Z75.5
ICD-10 Finland
Holiday relief care
8.3
12.1
26
32
S06.0
ICD-10 Finland
Concussion
2.4
12.1
111
504
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
13.6
12.0
20
15
N02BE01
ATC
paracetamol; systemic, rectal
1.9
11.8
789
6951
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.9
11.7
32
56
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
30.4
11.7
15
5
N87
ICD-10 Finland
Dysplasia of cervix uteri
+∞
11.5
11
*
N05AH02
ATC
clozapine; systemic
9.0
11.3
23
26
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
17.3
11.2
17
10
N28
ICPC
Limited function/disability (N)
4.7
11.2
37
81
J01EA01
ATC
trimethoprim; systemic
1.8
11.0
236
1500
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
10.8
90
388
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
7.3
10.8
25
35
G04BD08
ATC
solifenacin; oral
2.4
10.8
96
431
RF420
NOMESCO Finland
NA
6.8
10.7
26
39
K08.3
ICD-10 Finland
Retained dental root
2.5
10.7
84
354
G90.3
ICD-10 Finland
Multi-system degeneration
60.7
10.6
12
*
130
Kela drug reimbursment
Malignant tumour
0.2
10.5
14
570
AA5QN
NOMESCO Finland
NA
111.2
10.4
11
*
N03AX16
ATC
pregabalin; oral
1.8
10.4
225
1431
F0230, G20
ICD-10 Finland
NA
+∞
10.4
10
*
K02.1
ICD-10 Finland
Caries of dentine
1.6
10.3
418
3158
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.3
10.3
29
814
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.3
276
1870
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.7
10.2
28
50
M54.5
ICD-10 Finland
Low back pain
1.7
10.1
270
1824
R23
ICPC
Voice symptom/complaint
5.2
10.1
30
59
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.6
9.9
44
127
AA1AA
NOMESCO Finland
Head X-ray examination
7.1
9.8
23
33
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.0
9.7
55
188
N99
ICPC
Neurological disease other
6.2
9.7
25
41
N86
ICPC
Multiple sclerosis
13.5
9.7
16
12
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
9.6
61
227
WX110
NOMESCO Finland
Local anesthesy
1.6
9.6
548
4463
A04
ICPC
Weakness/tiredness general
2.0
9.6
133
725
F0232, G20
ICD-10 Finland
NA
+∞
9.4
9
*
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
7.0
9.3
22
32
G25.2
ICD-10 Finland
Other specified forms of tremor
10.8
9.3
17
16
M79.6
ICD-10 Finland
Pain in limb
1.6
9.2
306
2182
SPAT1262
SPAT
Handing over of treatment supplies
1.7
9.1
195
1229
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.3
9.1
82
370
R32
ICD-10 Finland
Unspecified urinary incontinence
3.5
9.1
41
121
H02AB06
ATC
prednisolone; systemic
0.6
9.1
237
3283
R33
ICD-10 Finland
Retention of urine
2.0
8.9
110
573
K59.0
ICD-10 Finland
Constipation
2.4
8.7
72
312
UKC02
NOMESCO Finland
Cystoscopy
1.7
8.7
209
1361
N04BX01
ATC
tolcapone; oral
50.4
8.7
10
*
R5110
SPAT
NA
3.5
8.7
39
115
S70.0
ICD-10 Finland
Contusion of hip
3.0
8.7
49
168
K03.66
ICD-10 Finland
Tooth plaque
2.6
8.7
62
248
SPAT1254
SPAT
Administration of medicine
1.8
8.6
163
991
RF410
NOMESCO Finland
NA
6.5
8.5
21
33
N08
ICPC
Abnormal involuntary movements
27.8
8.5
11
*
G24.9
ICD-10 Finland
Dystonia, unspecified
20.2
8.5
12
6
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.4
8.5
19
26
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
7.4
8.5
19
26
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.8
8.5
27
58
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.8
8.5
27
58
N06AX21
ATC
duloxetine; oral
2.2
8.4
88
427
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
8.4
76
345
N06AB04
ATC
citalopram; systemic
1.7
8.4
177
1111
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.3
127
2001
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
8.3
8
*
F0234, G20
ICD-10 Finland
NA
+∞
8.3
8
*
M41.9
ICD-10 Finland
Scoliosis, unspecified
5.0
8.2
25
51
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.1
8.2
43
143
R41.0
ICD-10 Finland
Disorientation, unspecified
2.9
8.1
48
173
L84
ICD-10 Finland
Corns and callosities
3.0
8.0
46
161
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
8.0
391
3028
H02AB02
ATC
dexamethasone; systemic
0.3
8.0
19
575
G35
ICD-10 Finland
Multiple sclerosis
7.3
8.0
18
25
J01CA08
ATC
pivmecillinam; oral
1.6
7.9
265
1881
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
7.7
433
5224
G21.8
ICD-10 Finland
Other secondary parkinsonism
18.5
7.6
11
6
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
10.1
7.5
14
14
H50.31
ICD-10 Finland
Intermittent exotropia
10.1
7.5
14
14
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
10.1
7.5
14
14
S01
ICD-10 Finland
Open wound of head
4.9
7.5
23
48
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
7.5
177
1145
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.4
267
1924
E86
ICD-10 Finland
Volume depletion
3.3
7.4
35
109
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
7.3
93
490
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.3
7.3
63
280
F023, G20
ICD-10 Finland
NA
+∞
7.3
7
*
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
7.3
7
*
R60.0
ICD-10 Finland
Localized oedema
1.8
7.2
121
705
M03BX01
ATC
baclofen; systemic
4.4
7.2
24
55
R4110
NOMESCO Finland
Physiotherapy
1.6
7.2
238
1679
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
7.1
49
192
L75
ICPC
Fracture: femur
4.6
7.1
23
51
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
7.0
158
1010
N06AX16
ATC
venlafaxine; oral
2.0
7.0
90
478
H50.52
ICD-10 Finland
Exophoria
7.6
6.9
15
20
RF210
NOMESCO Finland
NA
3.3
6.9
33
104
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.3
6.8
32
99
N30
ICD-10 Finland
Cystitis
2.4
6.8
55
238
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
6.8
399
3176
N04AA01
ATC
trihexyphenidyl; oral
40.3
6.8
8
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
6.7
145
913
M04AA01
ATC
allopurinol; systemic
0.5
6.7
53
1008
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
6.7
224
1577
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.1
6.6
*
194
XKC03
NOMESCO Finland
Water cystometry
2.8
6.6
40
148
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
6.6
286
2139
L03AA13
ATC
pegfilgrastim; parenteral
0.0
6.6
*
163
XKD00
NOMESCO Finland
Uroflowmetry
1.6
6.5
214
1501
H53.2
ICD-10 Finland
Diplopia
3.1
6.5
34
114
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.9
6.5
38
136
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.0
6.5
24
61
L03
ICPC
Low back symptom/complaint
1.6
6.5
192
1314
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
6.5
96
537
AA052
NOMESCO Finland
NA
70.3
6.4
7
*
S01.8
ICD-10 Finland
Open wound of other parts of head
4.7
6.4
20
43
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.2
6.4
7
318
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.8
6.4
25
67
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.8
6.4
39
145
WX402
NOMESCO Finland
General anaesthesia
1.7
6.4
132
823
G04BD04
ATC
oxybutynin; oral, transdermal
2.2
6.3
62
295
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
6.0
6.3
16
27
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
6.3
449
3691
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
6.3
75
388
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
18.1
6.3
9
5
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
6.3
6
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
6.3
6
*
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
6.3
6
*
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.4
6.2
28
85
W06
ICD-10 Finland
Fall involving bed
5.8
6.2
16
28
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
6.1
41
161
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.9
6.1
18
37
F05.9
ICD-10 Finland
Delirium, unspecified
3.2
6.1
29
92
WYA20
NOMESCO Finland
Home visit
4.0
6.0
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
58
28
21.82
77.33
2.1
1.2
105.87
160.53
nmol/l
0.61
31
19
785
6135
2.00
22.84
7.1
4.9
6902.62
1839.20
e6/l
0.64
21
112
695
8299
0.55
18.59
3.9
4.8
1.38
1.42
mmol/l
2.50
619
7421
665
8031
0.56
18.33
3.5
4.3
1.11
1.28
mmol/l
10.58
587
7116
706
8373
0.55
17.99
3.8
4.9
4.27
4.43
mmol/l
3.57
631
7561
337
2135
1.84
17.78
2.0
1.8
1228.16
1182.85
nmol/l
0.38
262
1587
489
3460
1.75
17.70
4.3
4.0
126.46
135.47
e6/l
0.09
365
2592
435
2987
1.76
17.42
2.7
2.2
240.76
243.20
u/l
0.02
418
2782
441
3076
1.73
16.46
3.8
3.6
31.16
96.07
e6/l
2.31
343
2448
503
3660
1.70
15.91
3.7
3.5
—
—
—
0
0
574
4351
1.68
15.36
5.2
4.0
0.00
0.00
estimate
0.00
117
821
405
2804
1.71
15.24
3.7
3.4
0.39
0.51
e6/l
0.71
314
2185
746
8594
0.58
14.48
4.3
5.5
2.48
2.57
mmol/l
1.72
664
7712
563
4338
1.62
13.40
7.3
5.4
0.00
0.00
estimate
0.00
114
823
547
4192
1.61
13.27
2.3
2.1
81.93
92.56
pmol/l
8.62
377
2191
569
4404
1.61
13.23
5.4
4.0
0.00
0.00
estimate
0.50
116
799
697
5696
1.62
12.71
4.6
5.0
6.47
6.87
mmol/l
6.69
677
5378
362
2529
1.65
12.64
1.8
1.6
18.90
20.25
nmol/l
1.04
327
2126
199
3102
0.56
12.08
2.6
3.3
46.31
297.58
mg/l
3.60
135
2014
554
4366
1.55
11.18
9.6
11.1
1.24
1.35
inr
2.44
154
1186
206
3123
0.58
11.05
2.6
3.2
7.42
7.46
mmol/l
0.05
169
2548
312
2165
1.62
10.90
2.8
2.7
5.31
4.32
e6/l
0.77
277
1926
441
3321
1.55
10.82
6.1
4.4
—
—
—
0
0
607
4953
1.51
9.93
5.0
7.1
1.21
1.21
mmol/l
0.28
510
4147
229
3289
0.62
9.54
3.5
4.0
6.90
9.32
mg/mmol
0.82
154
2108
327
2363
1.55
9.37
3.6
4.1
84.58
84.20
%
0.11
321
2310
256
1767
1.59
8.90
3.3
3.0
1.59
1.04
e6/l
0.81
150
1076
114
634
1.89
8.64
1.6
1.5
—
—
—
0
0
329
2425
1.51
8.45
5.5
4.3
0.00
0.00
estimate
0.50
107
773
306
2229
1.52
8.28
1.9
1.8
374.06
13878432.29
pmol/l
1.26
263
1787
731
8193
0.67
8.24
6.1
6.6
39.77
41.00
mmol/mol
3.41
663
7437
493
3967
1.44
7.98
5.1
4.1
40.85
56.65
ng/l
0.87
415
3103
529
4318
1.44
7.90
4.1
4.3
—
—
—
0
0
229
1606
1.54
7.28
2.3
2.0
29.40
30.05
s
1.05
224
1548
161
2380
0.62
7.19
1.3
1.7
1.24
1.33
mmol/l
1.16
130
1942
248
1799
1.49
6.67
1.8
1.9
—
—
—
0
0
233
1678
1.49
6.47
3.6
3.2
1.90
1.70
e6/l
0.16
126
993
773
8468
0.70
6.35
4.4
5.1
5.99
6.12
mmol/l
2.40
678
7530
539
4525
1.38
6.31
4.8
6.3
1.20
1.21
mmol/l
1.79
493
4073
184
1298
1.50
5.60
4.2
7.1
1.76
1.15
mmol/l
1.57
154
996
114
721
1.65
5.57
5.7
6.5
25.91
24.41
mmol/l
5.14
107
671
182
1289
1.49
5.43
4.2
7.1
5.27
5.08
kpa
2.09
174
1229
182
1290
1.49
5.41
4.2
7.1
12.37
11.77
kpa
0.75
173
1232
257
1947
1.42
5.38
5.4
4.4
1.02
1.02
kg/l
0.30
45
292
177
1255
1.49
5.25
1.8
1.8
—
—
—
0
0
426
3550
1.33
4.81
2.2
2.2
72.00
78.69
nmol/l
5.72
367
3070
48
245
2.00
4.75
4.9
3.5
7.38
7.74
mmol/l
0.46
48
240
85
520
1.69
4.73
2.3
2.6
0.69
0.66
%
0.44
80
505
50
260
1.97
4.70
4.7
3.4
1.51
1.61
mmol/l
0.40
50
255
173
1257
1.45
4.51
1.8
1.9
—
—
—
0
0
469
4001
1.30
4.35
2.5
2.3
—
—
—
0
0
161
1172
1.44
4.15
4.5
7.4
95.55
95.31
%
0.17
155
1126
154
1112
1.45
4.15
5.4
3.6
—
—
—
0
0
13
371
0.34
3.95
1.8
1.8
—
—
—
0
0
105
709
1.53
3.93
2.0
1.7
—
—
—
0
0
497
4315
1.28
3.89
4.0
5.0
34.79
34.59
g/l
0.34
460
3992
147
1068
1.44
3.83
4.7
7.8
122.40
120.54
g/l
0.52
139
1026
75
1153
0.62
3.82
3.3
4.2
3.20
24.89
ug/l
2.27
59
969
15
49
3.09
3.81
1.2
2.5
—
—
—
0
0
316
2602
1.30
3.70
2.5
2.2
3.42
3.11
mg/l
0.99
269
2195
43
750
0.56
3.59
1.4
1.7
1.44
1.63
%
1.99
38
612
18
68
2.67
3.57
2.8
2.4
—
—
—
0
0
202
2556
0.74
3.57
1.7
2.9
3377.70
8190.02
umol/l
1.27
151
2143
282
2314
1.30
3.35
2.2
2.5
—
—
—
0
0
58
355
1.67
3.29
3.2
3.7
3.85
3.97
mmol/l
1.46
53
325
84
1218
0.66
3.26
1.1
1.3
11.17
14.36
u/ml
0.17
31
404
52
838
0.60
3.24
1.2
1.3
—
—
—
0
0
83
559
1.52
3.18
3.8
3.3
25.64
25.24
mmol/l
0.62
76
539
15
56
2.70
3.06
1.7
1.4
—
—
—
0
0
136
1018
1.38
3.01
3.3
3.8
2.33
2.04
mmol/l
0.53
113
809
407
3532
1.24
2.98
2.8
2.8
128.06
161.13
ug/l
2.40
360
3174
20
88
2.30
2.95
2.9
2.1
2.70
2.40
u/field
—
10
30
92
1274
0.70
2.81
1.2
1.3
29.51
38.19
iu/ml
0.44
17
388
175
1378
1.32
2.79
4.5
6.8
106.13
104.16
mmol/l
5.81
168
1341
7
194
0.36
2.55
1.7
5.5
—
1041.93
iu/ml
—
0
30
97
707
1.41
2.53
4.2
8.8
0.75
0.68
%
1.02
97
701
22
416
0.52
2.47
2.7
2.8
—
—
—
0
0
236
1962
1.26
2.47
3.9
4.1
55.64
345.86
ng/l
7.07
193
1686
865
9038
0.79
2.46
8.6
11.5
14.46
25.31
u/l
117.92
774
8642
12
45
2.69
2.45
1.4
1.4
—
—
—
0
0
82
585
1.43
2.42
2.9
3.0
0.19
0.39
e6/l
1.29
77
575
6
12
5.02
2.40
2.7
2.7
0.83
0.50
u/field
—
6
12
341
2965
1.22
2.35
2.4
2.5
51.46
57.93
u/l
1.70
313
2724
92
1234
0.72
2.35
4.3
4.9
35.55
32.57
%
1.81
67
802
768
8095
0.83
2.16
18.8
16.6
83.42
73.29
ml/min/173m2
41.58
663
6719
107
825
1.33
2.01
3.2
3.9
1.22
1.22
mmol/l
0.02
89
711
10
231
0.43
2.01
1.6
1.3
—
—
—
0
0
891
8540
1.24
2.00
21.2
17.5
27.88
27.65
mg/l
0.07
795
6978
69
496
1.42
1.99
1.8
1.9
1.59
1.90
ug/l
0.14
54
437
94
712
1.35
1.99
4.3
8.6
1.32
1.35
%
0.13
94
706
5
139
0.36
1.89
1.0
1.2
—
—
—
0
0
221
2574
0.82
1.84
2.9
3.3
0.71
0.79
ug/l
0.49
159
1832
13
261
0.49
1.82
1.5
1.4
—
—
—
0
0
98
1241
0.77
1.72
1.7
4.1
235.91
250.02
u/l
0.57
87
1167
11
228
0.48
1.70
3.2
1.9
8.91
12.68
mg/l
1.22
11
208
7
158
0.44
1.55
1.1
1.1
—
—
—
0
0
16
282
0.56
1.51
2.0
3.3
0.71
0.84
nmol/l
0.41
11
224
33
220
1.52
1.45
2.5
3.9
20.81
29.77
mg/l
1.03
20
139
51
690
0.73
1.44
1.2
1.4
—
—
—
0
0
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
10
46
2.18
1.40
1.1
1.2
—
—
—
0
0
186
1609
1.19
1.33
2.0
3.3
0.83
0.81
mmol/l
1.27
174
1504
7
147
0.47
1.32
1.3
2.6
—
509.00
—
0
13
533
4986
1.14
1.30
3.7
6.5
11.07
12.12
umol/l
1.33
499
4716
9
175
0.51
1.29
1.3
1.3
—
—
—
0
0
29
424
0.68
1.29
2.7
3.5
23.13
9661.64
u/ml
0.83
24
356
14
243
0.57
1.29
1.1
1.8
—
—
—
0
0
55
720
0.75
1.27
1.7
2.2
12.85
12.54
nmol/l
0.10
46
622
10
49
2.05
1.22
2.0
1.5
1.30
4.20
u/field
—
10
35
442
4100
1.13
1.21
4.7
5.8
61.83
58.53
%
7.67
408
3824
21
323
0.64
1.20
1.7
1.6
—
155.38
—
0
13
17
273
0.62
1.18
1.9
2.5
145.10
119.75
ug/min
—
10
161
26
380
0.68
1.17
1.1
1.1
50.52
121.78
iu/ml
—
5
136
449
4181
1.13
1.14
4.8
6.0
23.80
25.97
%
4.38
410
3875
31
216
1.45
1.14
1.6
1.2
480.81
551.50
mg/l
0.51
31
201
0
36
0.00
1.14
0.0
1.3
—
26.84
—
0
25
130
1517
0.84
1.12
22.9
29.2
1.27
1.39
inr
0.42
14
196
8
40
2.01
1.12
1.5
2.7
—
—
—
0
0
8
40
2.01
1.12
1.5
2.7
—
—
—
0
0
660
6292
1.12
1.12
3.6
3.7
15.02
15.09
pmol/l
0.26
591
5554
212
1882
1.16
1.11
1.7
1.7
1.55
1.45
mg/l
0.14
164
1480
13
219
0.59
1.10
1.9
1.3
—
—
—
0
0
10
181
0.55
1.09
1.1
1.5
—
—
—
0
0
151
1308
1.18
1.08
1.6
2.5
1.51
1.79
%
3.26
130
1159
15
241
0.62
1.06
1.9
1.3
—
—
—
0
0
7
33
2.13
1.05
1.1
1.1
—
71.20
%
—
0
5
6
123
0.48
1.05
2.7
3.5
—
—
—
0
0
8
148
0.54
1.04
1.1
1.5
—
—
—
0
0
736
7080
1.12
1.02
5.1
8.0
79.50
80.82
u/l
0.32
679
6611
15
238
0.63
1.01
2.2
3.0
1.48
1.84
mg/l
1.09
15
210
5
108
0.46
1.01
1.0
1.0
—
—
—
0
0
709
6809
1.12
1.00
24.1
21.3
13.65
13.91
%
5.77
698
6644
20
296
0.67
0.99
1.9
1.6
—
—
—
0
0
25
174
1.45
0.95
1.9
2.0
1.94
1.64
mmol/l
0.49
25
169
31
227
1.38
0.91
1.4
1.4
—
—
—
0
0
31
227
1.38
0.91
1.4
1.4
—
—
—
0
0
91
767
1.20
0.91
1.7
1.7
—
—
—
0
0
52
412
1.28
0.90
1.7
1.8
—
—
—
0
0
30
221
1.37
0.86
1.6
1.6
—
—
—
0
0
8
44
1.82
0.86
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
411
0.75
0.84
2.2
2.6
0.40
0.36
u/ml
0.37
20
243
56
454
1.25
0.82
1.7
1.9
—
—
—
0
0
120
1365
0.86
0.79
3.3
5.8
1.02
1.03
mmol/l
0.27
111
1250
30
225
1.34
0.78
2.4
2.7
16.72
15.67
%
0.72
17
117
37
287
1.30
0.78
1.5
1.6
—
—
—
0
0
5
99
0.50
0.78
1.0
1.6
—
—
—
0
0
5
99
0.50
0.78
1.0
1.6
—
—
—
0
0
5
99
0.50
0.78
1.0
1.6
—
—
—
0
0
70
586
1.21
0.77
3.9
9.5
25.00
24.39
mmol/l
0.91
65
551
0
27
0.00
0.77
0.0
1.2
—
10.19
—
0
27
10
162
0.61
0.77
1.1
1.5
—
—
—
0
0
11
173
0.63
0.75
2.2
3.1
55.18
60.10
%
0.85
11
173
163
1466
1.13
0.74
2.1
2.6
2.29
2.24
g/l
0.44
147
1355
176
1593
1.13
0.72
2.3
2.6
10.25
12.39
umol/l
3.67
160
1473
14
206
0.68
0.71
1.5
1.5
—
—
—
0
0
9
144
0.62
0.70
1.1
1.2
—
41.31
—
0
14
292
2725
1.10
0.68
2.6
3.3
35.02
35.01
u/l
0.00
274
2580
5
27
1.86
0.68
1.2
1.1
—
1.08
—
0
6
7
118
0.59
0.68
1.9
1.6
—
—
—
0
0
674
6523
1.09
0.67
3.2
4.2
11.85
14.41
mm/h
4.61
616
5929
426
4476
0.92
0.67
4.3
5.5
3.58
3.07
ug/l
0.29
378
3962
31
394
0.78
0.66
1.2
3.9
23.62
62.50
mg/l
1.82
25
323
31
394
0.78
0.66
1.2
3.8
43.77
73.48
mg/l
0.96
26
320
42
340
1.24
0.66
1.2
1.3
—
—
—
0
0
30
234
1.29
0.63
1.3
2.7
28.17
33.21
umol/l
0.96
24
191
213
1966
1.10
0.63
2.6
3.3
2.44
2.46
mmol/l
2.14
180
1725
6
101
0.59
0.62
1.0
1.1
—
—
—
0
0
11
164
0.67
0.61
2.1
2.8
3.80
4.55
e9/l
0.64
11
164
528
5073
1.08
0.61
6.0
9.1
4.39
4.27
e9/l
0.45
456
4417
9
141
0.64
0.60
1.1
1.5
—
—
—
0
0
85
968
0.87
0.60
4.1
7.2
9.89
11.12
mmol/l
0.78
79
914
12
174
0.69
0.59
1.1
1.1
—
10.58
—
0
10
10
64
1.57
0.58
1.4
1.5
—
51.11
—
0
9
32
255
1.26
0.58
1.3
1.7
15147.64
16029.90
e6/l
0.04
25
187
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.9
—
—
—
0
0
12
172
0.69
0.56
1.1
1.3
—
—
—
0
0
13
183
0.71
0.55
1.0
1.1
—
—
—
0
0
915
9287
0.91
0.55
30.0
25.8
129.61
133.76
g/l
13.70
901
9100
8
122
0.65
0.55
1.8
1.6
—
—
—
0
0
42
349
1.21
0.54
1.1
2.8
38.14
36.86
g/l
0.74
35
300
915
9286
0.91
0.54
29.8
25.7
4.28
4.42
e12/l
13.07
888
8961
915
9285
0.91
0.54
29.7
25.7
241.78
237.76
e9/l
1.12
894
8994
24
302
0.79
0.50
1.0
1.0
—
—
—
0
0
96
861
1.13
0.50
2.4
2.4
37.75
39.53
u/l
0.08
84
730
12
84
1.43
0.49
1.1
1.1
104.83
110.66
%
0.24
12
77
39
326
1.20
0.49
1.1
2.9
0.00
0.03
g/l
0.86
34
300
346
3619
0.94
0.46
3.9
4.7
20.32
21.45
%
0.84
176
1906
10
142
0.70
0.46
1.0
1.1
—
—
—
0
0
13
176
0.74
0.46
1.7
1.6
—
—
—
0
0
37
310
1.20
0.46
1.1
3.0
0.00
0.00
g/l
0.00
32
285
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
8
120
0.66
0.45
1.8
1.6
—
—
—
0
0
8
120
0.66
0.45
1.8
1.6
—
—
—
0
0
8
121
0.66
0.45
1.8
1.6
—
—
—
0
0
8
121
0.66
0.45
1.8
1.6
—
—
—
0
0
7
51
1.37
0.44
2.1
1.1
338.00
283.61
mg/l
—
7
46
789
7744
1.07
0.43
4.6
4.6
2.02
2.04
mu/l
0.18
710
6881
31
257
1.21
0.43
1.2
1.2
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
501
5168
0.94
0.42
2.7
3.3
44.43
57.50
u/l
1.12
458
4704
31
258
1.21
0.42
1.2
1.2
—
—
—
0
0
6
95
0.63
0.42
1.2
1.3
—
—
—
0
0
21
261
0.80
0.41
1.0
1.6
—
—
—
0
0
341
3267
1.06
0.41
2.5
3.5
2.33
2.35
mmol/l
1.64
294
2803
43
370
1.17
0.41
1.1
3.1
0.16
1.49
g/l
4.25
33
321
0
16
0.00
0.41
0.0
1.3
—
27.66
—
0
11
0
17
0.00
0.40
0.0
1.8
—
2.20
—
0
8
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
20
248
0.80
0.39
1.1
1.6
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
16.57
—
0
14
67
747
0.89
0.39
4.4
3.2
77.38
59.41
ml/min/173m2
2.35
29
315
9
66
1.37
0.38
1.3
1.5
—
—
—
0
0
9
66
1.37
0.38
1.3
1.5
—
—
—
0
0
55
487
1.14
0.37
2.5
4.2
25.13
24.04
mmol/l
2.00
48
444
11
147
0.75
0.37
1.9
1.3
—
—
—
0
0
22
180
1.23
0.36
1.1
1.4
0.72
0.87
nmol/l
0.73
16
146
49
433
1.14
0.35
2.4
4.2
25.23
25.02
mmol/l
0.21
42
401
149
1398
1.08
0.34
2.3
2.7
19.21
22.37
%
1.79
123
1190
47
416
1.14
0.33
1.1
2.9
8.99
10.68
g/l
3.76
39
353
13
101
1.29
0.31
1.2
1.5
—
—
—
0
0
7
99
0.71
0.30
1.4
2.6
—
—
—
0
0
15
185
0.81
0.30
1.1
1.7
—
—
—
0
0
74
680
1.09
0.29
2.4
3.8
2.40
2.00
mmol/l
0.45
51
515
8
65
1.23
0.27
1.0
1.0
—
—
—
0
0
48
531
0.90
0.27
1.4
1.9
1.83
1.56
g/l
1.71
42
460
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
351
3416
1.04
0.24
2.7
3.1
1100.91
1760.46
ng/l
4.85
297
2965
14
115
1.22
0.23
1.2
1.5
—
—
—
0
0
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
48
440
1.10
0.21
1.1
2.9
3.47
3.79
g/l
1.28
35
319
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
48
441
1.09
0.20
1.1
2.9
6.81
7.46
g/l
2.00
35
330
48
441
1.09
0.20
1.1
2.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
13
154
0.84
0.19
1.1
1.6
—
—
—
0
0
6
52
1.15
0.19
1.3
1.5
—
—
—
0
0
6
52
1.15
0.19
1.3
1.5
—
—
—
0
0
915
9088
1.04
0.18
24.6
20.9
139.97
139.62
mmol/l
4.46
899
8840
25
223
1.12
0.18
2.0
1.6
—
—
—
0
0
28
253
1.11
0.17
2.1
3.0
8.33
7.73
kpa
1.73
28
228
5
68
0.73
0.17
1.0
1.4
—
—
—
0
0
129
1240
1.05
0.16
7.6
8.6
—
—
—
0
0
44
409
1.08
0.16
1.1
2.9
3.05
3.14
g/l
0.27
35
324
161
1558
1.04
0.15
1.2
1.2
1.25
1.36
u/ml
0.07
42
383
916
9106
1.04
0.15
24.5
21.0
3.96
4.01
mmol/l
8.17
898
8848
728
7347
0.97
0.15
22.3
19.1
36.89
38.72
%
3.23
431
4506
99
948
1.05
0.15
2.0
2.2
0.20
0.20
g/l
0.13
89
881
14
121
1.16
0.15
3.4
2.7
—
—
—
0
0
90
939
0.95
0.14
1.2
2.9
65.39
66.17
g/l
0.50
76
852
31
286
1.09
0.13
1.1
1.4
—
—
—
0
0
9
107
0.84
0.13
1.0
1.8
—
—
—
0
0
75
784
0.95
0.13
1.7
2.1
426.24
368.19
nmol/l
1.79
66
702
10
85
1.18
0.12
1.0
1.0
—
—
—
0
0
74
771
0.96
0.11
2.6
3.9
84.12
95.64
ng/l
0.89
55
662
104
1008
1.04
0.10
2.7
2.6
6.77
6.52
ug/l
0.07
80
879
75
724
1.04
0.09
2.4
3.8
5.11
5.17
kpa
0.28
67
670
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
6
57
1.05
0.08
1.7
1.4
—
—
—
0
0
6
57
1.05
0.08
1.7
1.4
—
—
—
0
0
34
322
1.06
0.08
1.1
1.3
—
—
—
0
0
30
283
1.06
0.08
1.3
1.5
274.98
274.77
ug/g
0.00
25
174
9
103
0.87
0.06
1.0
1.8
—
—
—
0
0
10
90
1.11
0.05
1.8
1.3
—
—
—
0
0
100
986
1.02
0.03
2.7
3.1
242.90
229.05
ng/l
0.11
92
907
11
117
0.94
0.01
1.1
1.7
—
—
—
0
0
106
1056
1.00
0.00
2.0
2.8
7.86
9.54
umol/l
0.40
94
938
14
139
1.01
0.00
1.1
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
9
92
0.98
0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
2.60
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
23.33
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
91.14
—
0
7
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
8.0
—
74.80
—
0
5
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
9
90
1.00
0.00
1.1
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
0.00
1.2
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR – Use of levodopa decarbox-comt-inhibitor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).